Reference
- van den BergLH, et al. Neurology. 2019;92(14):e1610–23.
References
- Küffner, et al. Nat Biotechnol. 2015;33:51.
- Taylor et al. Ann Clin Transl Neurol, 2016;3:866.
- Jahandideh et al. ALS FTD. 2018;19(3–4), 294.
- Berry et al. Ann Clin Transl Neurol. 2018;5:474.
- BreimanL. Mach Learn. 2001;45:261. https://www.stat.berkeley.edu/∼breiman/randomforest2001.pdf
- FriedmanJH. Ann Stat. 2001;29(5):1189–232. https://www.jstor.org/stable/2699986?seq =1#page_scan_tab_contents
- Hastie, et al. 2009. The Elements of Statistical Learning. P249 & ff. https://web.stanford.edu/∼hastie/Papers/ESLII.pdf
Reference
- PalumboJM, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019. [Epub ahead of print].
Reference
- GaurN, et al. Amyotroph Lat Scler Frontotemporal Degener. 2017;18.
References
- BenatarM, WuuJ, AndersenPM, et al. Neurology. 2018;90:e565–e574.
- CudkowiczME, ShefnerJM, SimpsonE, et al. Muscle Nerve. 2008;38:837–844.
Reference
- EliaAE, LalliS, MonsurròMR, et al. Eur J Neurol. 2016;23(1):45–52.
Reference
- BeckAT, SteerRA, BrownGK. Manual for the Beck Depression Inventory - Fast Screen for Medical Patients. San Antonio, TX: Psychological Corporation; 2000.
Reference
- Watanabe, et al. J Neurol Neurosurg Psychiatry. 2016.
References
- Taylor, et al. Ann Clin Transl Neurol. 2016.
- Berry, et al. Ann Clin Transl Neurol. 2018.
- Jahandideh, et al. ALS FTD. 2018.
References
- BeersD, AppelS. Lancet Neurol. 2019;18:211–20.
- SheeanR, McKayF, CretneyE, et al. JAMA Neurol. 2018; 75:681–9.
- MillikenS, WassallH, LewisB, et al. JACI. 2012; 129:1554–61.
- KaramC, BarrettMJ, ImperatoT, et al. J Clin Neurosci. 2013; 20:1550–3.
Reference
References
- TakeiK, TakahashiF, LiuS, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:49–54.
- Writing group on behalf of the edaravone (MCI-186) ALS 18 study group. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:40–48.
- TakeiK, TsudaK, TakahashiF, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:88–97.
- Writing Group; Edaravone (MCI-186) ALS 19 Study Group 2017. Lancet Neurol. 2017;16:505–12.
Reference
- Writing Group on behalf of the Edaravone (MCI-186) ALS 19 Study Group. Lancet Neurol. 2017;16:505–12.
Reference
- Writing Group; Edaravone (MCI-186) ALS 19 Study Group. Lancet Neurol. 2017;16:505–12.
References
- RADICAVA® (edaravone injection) [package insert]. Jersey City, NJ: Mitsubishi Tanabe Pharma America, Inc; 2018.
- Writing Group; Edaravone (MCI-186) ALS 19 Study Group. Lancet Neurol. 2017;16:505–512.